Fig. 1 · Structure
Documents & Downloads
Sprodiamide
MRI Contrast Agent
Sprodiamide (Dy-DTPA-BMA) is a susceptibility-based MRI contrast agent that enhances image contrast by detecting changes in magnetic susceptibility during the vascular transport of drugs. Its primary mechanism involves improving the visibility of dynamic processes within the vascular system, making it valuable for studying drug delivery systems and assessing vascular health. Sprodiamide is instrumental in research applications related to drug transport mechanisms and imaging in preclinical studies.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 128470-17-7 |
| Applications | MRI Contrast Agent |
| Formula | C16H26DyN5O8 |
| Molecular Weight | 578.91 |
| Synonyms | Dy-DTPA-BMA |
| SMILES | CNC1=O[Dy+3]234([O-]5)([O-]6)([O-]7)[N](CC[N]2(CC6=O)CC[N]3(CC5=O)CC(NC)=O4)(CC7=O)C1 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.